Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC5188 Tol8-agonist-31a

Novel Human Toll-like Receptor 8-Selective Agonist

DCC5189 Toldimfos Sodium

Stimulator of metabolism, preventing diseases associated with parturition and peri-partum period, developmental and nutritional disorders in young animals, and bone growth disorders and tetany or paresis caused by calcium, magnesium, and phosphorus metabo

575-75-7
DCC5190 Tonantzitlolone

Natural agonist of TPRC1/4/5 channels, also acting as a dual PKCα and PKCθ activator, inducing an insulin resistant phenotype by inhibiting IRS1 and the PI3K/Akt pathway, activating the heat shock factor 1 (HSF1) transcription factor driving glucose depen

845811-30-5
DCC5191 Top1/tdp1-in-c12

Novel dual TOP1 and TDP1 inhibitor, inducing both cellular TOP1cc, TDP1cc formation and DNA damage, resulting in cancer cell apoptosis at a sub-micromolar concentration

DCC5192 Top1210

Novel narrow spectrum kinase inhibitor, potently inhibiting P38a, Src, and Syk kinase activities

1628439-59-7
DCC5193 Top-dnj

Novel Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II, Exhibiting Antiflaviviral Activity

1508303-85-2
DCC5194 Topki-nbd

Novel highly specific fluorescent TOPK inhibitor

DCC5195 To-pro3 Iodide

Nucleic acid stain, acting on viable, early apoptotic and necrotic cells differentially, showing specific staining of nuclei without any staining of the cytoplasm

157199-63-8
DCC5196 Tortuosamine

Natural psychoactive agent

DCC5197 Tos-gly-pro-arg-anba-ipa

Chromogenic peptide substrate for the rapid and specific photometric assay of recombinant hirudin (r-hirudin)

99700-50-2
DCC5198 Tosylaniline

Selective CA IX inhibitor

68-34-8
DCC5199 Toxt-in-8

Novel ToxT inhibitor, reducing Vibrio cholerae virulence in vivo and effectively inhibiting intestinal colonization in the infant mouse

DCC5200 Tp-008

Novel probe for activin receptor-like kinase (ALK4 and ALK5)

DCC5201 Tp-040

Novel inhibitor of O-GlcNAcase (OGA)

DCC5202 Tp-238 Hydrochloride

Novel probe for CECR2/BPTF bromodomains

2415263-05-5
DCC5203 Tpe-gal

First-in-class fluorescent drug delivery vesicle that can efficiently load both water-soluble and -insoluble anticancer drugs

DCC5204 Tph1-in-23a

Novel Peripheral Selective Tryptophan Hydroxylase 1 (TPH1) Inhibitor (IC 50 : 42nM) for Obesity and Fatty Liver Disease

DCC5205 Tpi1609-10

Inhibitor of tyrosine recombinases and Holliday junction-resolving enzymes; Antibacterial

1374458-85-1
DCC5206 Tpi-1917-49

Promising amyloid reducing agent by lowering the levels of Aβ.

1250849-11-6
DCC5207 Tpi-2659-17

Novel Specific Inhibitor of Type I Collagen Production in Fibrosis

DCC5208 Tpi-287

Novel taxane family member, reducing the brain metastatic colonization of breast cancer cells

849213-15-6
DCC5209 Tpl2-in-i

Novel tumour progression locus 2 (Tpl2) kinase inhibitor

915009-13-1
Page 1458 / Total 1558 FirstPrevNextLastGoto